UnknownNot Applicable

The Reliability and Validity of the Ankylosing Spondylitis Performance Index (ASPI) in Enthesitis-Related Arthritis

Turkey (Türkiye)40 participantsStarted 2024-03-21

Plain-language summary

This study assesses the test-retest reliability, construct validity, and minimal detectable change of the Ankylosing Spondylitis Performance Index (ASPI) in assessing the physical function of patients with Enthesitis-related arthritis (ERA).

Who can participate

Age range7 Years – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Being diagnosed with Enthesitis-Related Arthritis (ERA) according to The International League of Associations for Rheumatology (ILAR) classification * Being between the ages of 7-18 * Volunteering to participate in research Exclusion Criteria: * Advanced heart/lung/liver/kidney disease, neurological disease and malignancies * Having undergone major orthopedic surgery * The presence of moderate to severe mental problems that will negatively affect participation * Not volunteering to participate in the study

What they're measuring

Ankylosing Spondylitis Performance Index (ASPI)

Timeframe: Baseline (First assessment)

Trial details

NCT IDNCT06383195

SponsorHacettepe University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-03-20

Contact for this trial

Sinan Buran, RA

+903123052525 pt.sinanburan@gmail.com

View on ClinicalTrials.gov More Enthesitis Related Arthritis trials